跳至主要内容
临床试验/IRCT20190916044785N1
IRCT20190916044785N1招募中3 期

Evaluation of The Effect of Nanocurcumin on Treatment of Tinnitus:A Triple Blinded Randomized Clinical Trial

Hamedan University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Unilateral or Bilateral Subjective Tinnitus
  • Age Range: 18-65 Year
  • Patients do not have Pregnancy and Breastfeeding
  • Patients do not have Acute or Chronic Ear Infection
  • Patients do not have Rheumatologic Diseases, Vasculitis, Acoustic Neuroma, Known Neurological Disorders and Ear Surgery
  • Patients not taking Immunosuppressants such as Interferons, Corticosteroids, Anticonvulsants and Sedatives before starting the study

排除标准

  • Patients who do not willing to enter the study

研究者

相似试验